ReportGem ReportGem 中文

REAL-TIME GLOBAL RESEARCH

Carl Zeiss Meditech; Fresenius Medical: EU Healthcare Sector Specialist Commentary Pharma • Biotech • Medtech

Published: 2026-07-17Institution: JPMorganPages: 6Original language: EnglishEvidence page: 3

Research evidence excerpt

Carl Zeiss Meditech; Fresenius Medical: EU Healthcare Sector Specialist Commentary Pharma • Biotech • Medtech

Marjan Daeipour - Specialist Sales - European Healthcare AC (44 20) 7134-1329 Europe Specialist Sales J P M O R G A Nmarjan.daeipour@jpmorgan.com

J.P. Morgan Securities plc 17 July 2026

Healthcare Trading:

Mark O’Sullivan (EU) mark.osullivan@jpmorgan.com+44 207 134 0542

Jacqueline Bukzin jacqueline.bukzin@jpmchase.com

US Derivatives: Leon Aboudi leon.aboudi@jpmorgan.com+1 646 408 7356

Pharma Research:

Richard Vosser richard.vosser@jpmorgan.com+44 207 742 6652

Chris Schott (US) Christopher.schott@jpmorgan.com+1212 622 5676

Seiji Wakao (JPN) seiji.wakao@jpmorgan.com +81 367 36 8612

Jihyun Cho (Korea) jihyun.cho@jpmorgan.com+82 2 779 0554

Zain Ebrahim (EU) zain.ebrahim@jpmorgan.com+44 020 34931163

Sophia Graeff Buhl Nielsen (EU) sophia.graeffbuhlnielsen@jpmorgan.com +44 020 77423918

Biotechnology Research:

Jessica Fye (US) Jessica.m.fye@jpmorgan.com+1 212 622 4165

Anupam Rama (US) anupam.rama@jpmorgan.com+1 212 622 0900

Tessa Romero (US) Tessa.T.Romero@jpmorgan.com +1 212 622 4484

Brian Cheng brian.cheng@jpmorgan.com +1 212 622 0449

MedTech Research:

David Adlington (EU) david.adlington@jpmorgan.com+44 207 134 5828

Robbie Marcus (US) robert.j.marcus@jpmorgan.com+1 212 622 6657

Life Science Tool & Diagnostics:

Casey Woodring Casey.Woodring@jpmchase.com+1 212 622 9074

Managed Care, Facilities, Distribution, Technology & PBMs:

Lisa Gill lisa.c.gill@jpmorgan.com+1 212 622 6466

John Stansel John.Stansel@jpmorgan.com+1212 622 0083

Benjamin Rossi Benjamin.Rossi@jpmorgan.com+1 212 622 9603

Alex Comer (CEEMEA) Alex.r.comer@jpmorgan.com+44 207 134 5945

Disclaimers:

This communication is intended for institutional and selected professional clients of J.P. Morgan only.

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer